Back to journals
Academic JournalOpen Access

Clinical Psychopharmacology and Neuroscience

1 Papers Indexed in Blossom

Data updated

Research Footprint

Clinical Psychopharmacology and Neuroscience has 1 tracked paper indexed in Blossom (2021) from 7 authors, most often covering Ketamine, Esketamine and Placebo, across Major Depressive Disorder (MDD), Treatment-Resistant Depression (TRD) and Depressive Disorders.

Published Papers

Open Accessmeta

Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistance Depression and Major Depression with Suicide Ideation: A Meta-Analysis

This meta-analysis (s=7; n=1488) of double-blind placebo-controlled studies with those suffering from depression (MDD; TRD) and suicidal ideation (SI) found that esketamine (24-84mg) significantly improved scores on a measure of depression (MADRS) over the placebo up to 28 days alter, the SI scores were only significant within the first 24 hours.

Published
Journal
Clinical Psychopharmacology and Neuroscience
Authors
Bahk, W., Wang, S., Kim, N., Lim, H., Woo, Y., Pae, C., Na, H.

Quick Facts

Papers Indexed
1
h-Index
47
Open Access
Yes
Publisher
Korean College of Neuropsychopharmacology
Country
South Korea
Website
Visit